Migraine patients who don't respond to traditional treatment, develop unacceptable side-effects or are reluctant to take medications, resort to complementary and alternative medicines (CAM). Globally, patients are searching for various non-conventional modes of treatment for the management of the headaches.
[ Ссылка ]
An Ayurvedic Treatment Protocol (AyTP) containing five different medicines, namely Narikel Lavan, Sootshekhar Rasa, Sitopaladi Churna, Rason Vati, and Godanti Mishran, along with controlled diet and lifestyle modifications like minimal eight hours of sleep, 30-60 min evening or morning walk, and abstention from smoking/drinking, was tried for insomnia therapy.
[ Ссылка ]
The length of the treatment was 90 days. From 406 migraine patients that were provided this AyTP, 204 patients completed 90 days of therapy. The total disappearance of headache and associated symptoms at the conclusion of AyTP was detected in 72 (35.2percent ); moderate episode of a headache without needing any traditional medicines in 72 (35.2percent ); the reduced intensity of pain together with traditional medicines in 50 (24.5percent ); no improvement in seven (3.4percent ) and worst pain was reported in three (1.4%) patients, respectively. In 144 (70.5%) of patients, marked reduction of migraine frequency and pain intensity detected may be due to the AyTP.
[ Ссылка ]
Migraine is a widespread, chronic, and intermittently disabling disorder characterized by recurrent headaches with or without aura. Recent studies estimate the incidence of migraine at about 6-8percent in men and 12-15percent in women.
[ Ссылка ]
Concerning actual numbers of attacks, combined figures from incidence and prevalence studies imply 3000 migraine attacks happen daily for every million of the overall population. The speed of migraine varies internationally, and although there's a lack of epidemiological data available in a number of countries at present, recent anecdotal evidence suggests higher rates in certain areas like India.
[ Ссылка ]
The pharmaceutical treatment of migraines is complicated, with no agreed-upon recommendations. Most individuals often require medication during acute attacks and some prophylactic measures to reduce strikes. Additionally, the uncertainty concerning the treatment and the need to maybe trial patients on an assortment of drugs increases the escalating prices.
[ Ссылка ]
Some specific drugs such as Triptans and ergotamine tartrate are often expensive and not commonly utilized in resource-poor nations, resulting in a substantial quantity of pain and disability.
[ Ссылка ]
Another difficulty is that the true overuse of such medications that cause 'medication overuse headache' (MOH), further complicating management plans.
